Computational Insights into Aldose Reductase Inhibition by Soy Isoflavones: A Pathway To Diabetes Mitigation
- 13 December 2025
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (1) , 63
Abstract
No abstract availableKeywords
Funding Information
- Bangladesh Council of Scientific and Industrial Research (Project: IFST-06, 2024-2025)
- Bangladesh Council of Scientific and Industrial Research (Project: IFST-06, 2024-2025)
- Bangladesh Council of Scientific and Industrial Research (Project: IFST-06, 2024-2025)
- Bangladesh Council of Scientific and Industrial Research (Project: IFST-06, 2024-2025)
- Bangladesh Council of Scientific and Industrial Research (Project: IFST-06, 2024-2025)
This publication has 80 references indexed in Scilit:
- Isoflavones: Promising Natural Agent for Cancer Prevention and TreatmentFood Science & Nutrition, 2025
- De novo in silico screening of natural products for antidiabetic drug discovery: ADMET profiling, molecular docking, and molecular dynamics simulationsIn Silico Pharmacology, 2025
- Exploration of leads from bis-indole based triazine derivatives targeting human aldose reductase in diabetic type 2: in-silico approaches3 Biotech, 2024
- Introducing KICK-MEP: exploring potential energy surfaces in systems with significant non-covalent interactionsJournal of Molecular Modeling, 2024
- Identification of potential key lipid metabolism-related genes involved in tubular injury in diabetic kidney disease by bioinformatics analysisActa Diabetologica, 2024
- The Gene Network Correlation Analysis of Obesity to Type 1 Diabetes and Cardiovascular Disorders: An Interactome-Based Bioinformatics ApproachMolecular Biotechnology, 2023
- In silico DFT study, molecular docking, and ADMET predictions of cytidine analogs with antimicrobial and anticancer propertiesIn Silico Pharmacology, 2021
- Glycitein induces reactive oxygen species‐dependent apoptosis and G0/G1 cell cycle arrest through the MAPK/STAT3/NF‐κB pathway in human gastric cancer cellsDrug Development Research, 2019
- Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancerCellular Oncology, 2017
- Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidneyJournal of Biochemical and Molecular Toxicology, 2017